These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23441721)

  • 1. Posttransfusion platelet increments after different platelet products in neonates: a retrospective cohort study.
    Honohan A; van't Ende E; Hulzebos C; Lopriore E; van't Verlaat E; Govaert P; Brand A; van der Bom J
    Transfusion; 2013 Dec; 53(12):3100-9. PubMed ID: 23441721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.
    Bakchoul T; Bassler D; Heckmann M; Thiele T; Kiefel V; Gross I; Arnold DM; DiTomasso J; Smith JW; Paes B; Greinacher A
    Transfusion; 2014 Mar; 54(3):640-5. PubMed ID: 23869512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions.
    Drawz SM; Marschner S; Yañez M; García de Coca A; Feys HB; Deeren D; Coene J
    Transfusion; 2015 Jul; 55(7):1745-51. PubMed ID: 25702711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
    Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
    Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.
    Sigle JP; Infanti L; Studt JD; Martinez M; Stern M; Gratwohl A; Passweg J; Tichelli A; Buser AS
    Transfusion; 2013 Aug; 53(8):1788-97. PubMed ID: 23176347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower or higher doses for prophylactic platelet transfusions: results of a meta-analysis of randomized controlled trials.
    Cid J; Lozano M
    Transfusion; 2007 Mar; 47(3):464-70. PubMed ID: 17319827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.
    Honohan A; Tomson B; van der Bom J; de Vries R; Brand A
    Transfusion; 2012 Apr; 52(4):742-51. PubMed ID: 21981629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison.
    van Hout FMA; van der Meer PF; Wiersum-Osselton JC; Middelburg RA; Schipperus MR; van der Bom JG; Kerkhoffs JL
    Transfusion; 2018 Apr; 58(4):1021-1027. PubMed ID: 29405304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the effectiveness of whole blood-derived platelets stored as a pool: a randomized block noninferiority trial.
    Heddle NM; Cook RJ; Blajchman MA; Barty RL; Sigouin CS; Boye DM; Nelson EJ; Kelton JG
    Transfusion; 2005 Jun; 45(6):896-903. PubMed ID: 15934987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient and product factors affecting platelet transfusion results.
    Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
    Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and safety of riboflavin and UV light-treated platelet transfusions in children over a five-year period: focusing on neonates.
    Jimenez-Marco T; Garcia-Recio M; Girona-Llobera E
    Transfusion; 2019 Dec; 59(12):3580-3588. PubMed ID: 31587287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of platelet transfusion triggers in a tertiary-care hospital.
    Cameron B; Rock G; Olberg B; Neurath D
    Transfusion; 2007 Feb; 47(2):206-11. PubMed ID: 17302765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).
    Wiita AP; Nambiar A
    Transfusion; 2012 Oct; 52(10):2146-54. PubMed ID: 23113654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
    Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J
    Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit.
    Gerday E; Baer VL; Lambert DK; Paul DA; Sola-Visner MC; Pysher TJ; Christensen RD
    Transfusion; 2009 Oct; 49(10):2034-9. PubMed ID: 19555422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
    Enein AA; Hussein EA; El Shafie S; Hallouda M
    J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function in variable platelet split products intended for neonatal transfusion.
    Strasser EF; Stachel DK; Schwarzkopf P; Ringwald J; Weisbach V; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2006 May; 46(5):757-65. PubMed ID: 16686843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.
    Julmy F; Ammann RA; Taleghani BM; Fontana S; Hirt A; Leibundgut K
    Transfusion; 2009 Jan; 49(1):21-33. PubMed ID: 18774963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.